iHCK-37 (ASN05260065) is a selective Hck inhibitor that blocks HIV-1 replication and exhibits antitumor activity. It suppresses erythropoietin-induced PI3K/AKT and MAPK/ERK signaling in high Hck-expressing cells, making it a useful research tool for studying chronic myelogenous leukemia (CML) in vitro.
Molekulargewicht:
544.73
Reinheit:
99.97% (May vary between batches)
CAS Nummer:
[516478-09-4]
Formel:
C30H32N4O2S2
Target-Kategorie:
Hck,Src
Anwendungsbeschreibung:
Solubility: DMSO:200 mg/mL (367.15 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
